The North America Single-use Filtration Assemblies Market should witness market growth of 17.2% CAGR during the forecast period (2022-2028).
The popularity of single-use filtering assemblies has grown. For final and bulk-fill processes, some biopharmaceutical companies use filtration assemblies that only need to be used once. The main things that are making the market grow are the growth of the life sciences, faster implementation, and higher demand for biopharmaceuticals. The single-use filtration assemblies market is expected to grow due to rising R&D efforts and reduced danger of cross-contamination.
As a result of its capacity to offer a contamination-free alternative to conventional stainless-steel systems, the market has experienced a boom in popularity. In addition, these filtration assemblies can be created without the accompanying validation procedures and sterilization steps because of reinforced hose and welding applications. For final and bulk-fill processes, many biopharmaceutical firms opt for single-use filtration assemblies to keep equipment sterile. This has been made possible by growth in life sciences R&Dactivities, a rise in the market for biopharmaceuticals, reduced risk of cross-contamination, and faster deployment.
The expansion of the U.S. biopharmaceutical industry is anticipated to be bolstered by several significant variables, including the soaring elderly population, fewer marketed generics, and the robust pipeline of biopharmaceuticals. In the coming years, the strong lobbying influence of several biopharma companies, fewer patent expiries, and the growth of indicators are anticipated to contribute to the industry's growth. In addition, it is anticipated that a large increase in FDA-approved biopharmaceutical medicines will generate attractive prospects throughout the projected period. Each of these variables is anticipated to significantly contribute to the market's growth.
The US market dominated the North America Single-use Filtration Assemblies Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,168.6 million by 2028. The Canada market is poised to grow at a CAGR of 19.9% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 18.8% during (2022-2028).
Based on Application, the market is segmented into Bioprocessing/Biopharmaceuticals, Pharmaceuticals Manufacturing and Laboratory Use. Based on Type, the market is segmented into Membrane Filtration, Depth Filtration, Centrifugation and Others. Based on Membrane Filtration Type, the market is segmented into Tangential Flow Filtration (TFF) and Others. Based on Product, the market is segmented into Filters, Membranes, Cassettes, Cartridges, Manifold, Syringes and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Sartorius AG, Repligen Corporation, Merck Millipore (Merck Group), Danaher Corporation, Thermo Fisher Scientific, Inc., Meissner Filtration Products, Inc., Cellab CDMO, Medela AG, and DrM, Dr. Mueller AG.
The popularity of single-use filtering assemblies has grown. For final and bulk-fill processes, some biopharmaceutical companies use filtration assemblies that only need to be used once. The main things that are making the market grow are the growth of the life sciences, faster implementation, and higher demand for biopharmaceuticals. The single-use filtration assemblies market is expected to grow due to rising R&D efforts and reduced danger of cross-contamination.
As a result of its capacity to offer a contamination-free alternative to conventional stainless-steel systems, the market has experienced a boom in popularity. In addition, these filtration assemblies can be created without the accompanying validation procedures and sterilization steps because of reinforced hose and welding applications. For final and bulk-fill processes, many biopharmaceutical firms opt for single-use filtration assemblies to keep equipment sterile. This has been made possible by growth in life sciences R&Dactivities, a rise in the market for biopharmaceuticals, reduced risk of cross-contamination, and faster deployment.
The expansion of the U.S. biopharmaceutical industry is anticipated to be bolstered by several significant variables, including the soaring elderly population, fewer marketed generics, and the robust pipeline of biopharmaceuticals. In the coming years, the strong lobbying influence of several biopharma companies, fewer patent expiries, and the growth of indicators are anticipated to contribute to the industry's growth. In addition, it is anticipated that a large increase in FDA-approved biopharmaceutical medicines will generate attractive prospects throughout the projected period. Each of these variables is anticipated to significantly contribute to the market's growth.
The US market dominated the North America Single-use Filtration Assemblies Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,168.6 million by 2028. The Canada market is poised to grow at a CAGR of 19.9% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 18.8% during (2022-2028).
Based on Application, the market is segmented into Bioprocessing/Biopharmaceuticals, Pharmaceuticals Manufacturing and Laboratory Use. Based on Type, the market is segmented into Membrane Filtration, Depth Filtration, Centrifugation and Others. Based on Membrane Filtration Type, the market is segmented into Tangential Flow Filtration (TFF) and Others. Based on Product, the market is segmented into Filters, Membranes, Cassettes, Cartridges, Manifold, Syringes and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Sartorius AG, Repligen Corporation, Merck Millipore (Merck Group), Danaher Corporation, Thermo Fisher Scientific, Inc., Meissner Filtration Products, Inc., Cellab CDMO, Medela AG, and DrM, Dr. Mueller AG.
Scope of the Study
By Application
- Bioprocessing/Biopharmaceuticals
- Pharmaceuticals Manufacturing
- Laboratory Use
By Type
- Membrane Filtration
- Tangential Flow Filtration (TFF)
- Others
- Depth Filtration
- Centrifugation
- Others
By Product
- Filters
- Membranes
- Cassettes
- Cartridges
- Manifold
- Syringes
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- 3M Company
- Sartorius AG
- Repligen Corporation
- Merck Millipore (Merck Group)
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Meissner Filtration Products, Inc.
- Cellab CDMO
- Medela AG
- DrM, Dr. Mueller AG
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. North America Single-use Filtration Assemblies Market by Application
Chapter 5. North America Single-use Filtration Assemblies Market by Type
Chapter 6. North America Single-use Filtration Assemblies Market by Product
Chapter 7. North America Single-use Filtration Assemblies Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- 3M Company
- Sartorius AG
- Repligen Corporation
- Merck Millipore (Merck Group)
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Meissner Filtration Products, Inc.
- Cellab CDMO
- Medela AG
- DrM, Dr. Mueller AG
Methodology
LOADING...